期刊文献+

脉冲给药系统研究进展 被引量:6

Progress in pulsatile drug delivery system
在线阅读 下载PDF
导出
摘要 脉冲给药系统是随着时辰生物学和时辰药理学研究的不断深入而发展起来的,是以制剂手段控制药物释放时间及给药剂量来配合生理节律的变化,从而保证疗效,减轻不良反应,临床应用前景良好。为此,本文综述国内外的相关文献,简要介绍了脉冲给药系统的释药机理,并讨论了近年来脉冲给药系统在临床上的应用情况,提出了中药复方脉冲制剂在研究中所存在的一些问题,期望为中药脉冲给药系统的研究提供思路。 Pulsatile drug delivery system developed quickly with the further study of chronobiology and chronopharmacology,which controled drug release and dosage by the method of formulation,and could coordinate the change of physiological rhythm,furthermore ensure efficacy and reduce adverse reaction.The characteristics and drug release mechanism of pulsatile drug delivery system were introduced and the clinical applications of pulsatile drug delivery system in recent years were discussed.
出处 《药学实践杂志》 CAS 2012年第5期326-330,343,共6页 Journal of Pharmaceutical Practice
基金 "重大新药创制"科技重大专项(2009ZX09502-008) 国家自然科学基金面上项目(81073057) 国家自然科学青年基金项目(81102816) 教育部博士点基金(20090013110007) 北京中医药大学自主选题项目(2011JYB22XZ-063)
关键词 脉冲给药系统 释药机理 生物节律 剂型 时辰药理学 pulsatile drug delivery system drug release mechanism biological rhythm dosage form chronopharmacology
  • 相关文献

参考文献33

  • 1廖华.缓控释制剂简介[J].湖北中医杂志,2008,30(12):51-52. 被引量:2
  • 2Rane AB, Gattani SG , Kadam VD,et al. Foru-ulation and eval- uation of press coated tablets for pulsatile drug delivery using hy- drophilic and hydrophobic polymers[J].Chem Pharm Bull (To- kyo),2009,57(11) :1213.
  • 3杨金有.生物节律与合理用药[J].中国实用医药,2010,5(5):241-243. 被引量:1
  • 4袁源,刘保安.昼夜节律与肿瘤的相关研究进展[J].现代生物医学进展,2009,9(5):976-978. 被引量:4
  • 5Smolensky MH, Peppas NA. Chronobiology, drug delivery, and chronotherapeutics [ J ]. Adv Drug Deliv Rev ,2007,59 ( 9-10 ) :828.
  • 6Youan BB. Chronopharmaceutics: gimmick or clinically relevant ap- proach to drug delivery? [J]. J Control Release,2004,98(3) :337.
  • 7丛绍强,王延文,王智亮.中药时辰药理学的研究进展[J].泰山卫生,2005,29(1):11-12. 被引量:1
  • 8潘颖,杨劼.脉冲释药系统[J].河北医药,2005,27(11):862-863. 被引量:5
  • 9Lin HL, Lin SY, Lin YK, et al. Release characteristics and in vitro-in vivo correlation of pulsatile pattern for a pulsatile drug de- livery system activated by membrane rupture via osmotic pressure and swelling[ J ]. Eur J Pharm Biopharm, 2008,70 ( l ) :289.
  • 10Fan TY, Wei SL, Yan WW, et al. An investigation of pulsatile release tablets with ethylcellulose and Eudragitl as film coating materials and cross-linked polyvinylpyrrolidone in the core tablets [ J]. J Control Release ,2001,77 (3) :245.

二级参考文献195

共引文献143

同被引文献48

  • 1潘颖,杨劼.脉冲释药系统[J].河北医药,2005,27(11):862-863. 被引量:5
  • 2张莉,陈大为,高子彬.法莫替丁定时释放小丸的释药机制[J].药学学报,2006,41(9):873-877. 被引量:3
  • 3Schapira A H, Jenner P. Etiology and pathogenesis of Parkinson's disease [ J ]. Mov Disord, 2011, 26 ( 6 ) : 1049-1055.
  • 4George P, Charles W. The rat brain in stereotaxic coordi- nates[M]. 5th ed. San Diego: Elsevier, 2007: 456.
  • 5Choi D Y, Liu M, Hunter R L, et al. Striatal neuroin- flammation promotes Parkinsonism in rats [ J ]. Plos One, 2009, 4 ( 5 ) : e5482.
  • 6Zaheer F, Slevin J T. Trichloroethylene and Parkinson disease [ J ]. Neurol Clin, 2011, 29 (3) :657-665.
  • 7Meredith G E, Sonsalla P K, Chesselet M F. Animal models of Parkinson's disease progression[J]. Acta Neu- ropathol, 2008, 115(4) :385-398.
  • 8Philippens I H, Wubben J A, Finsen B, et al. Oral treatment with the NADPH oxidase antagonist apocynin mitigates clinical and pathological features of parkinson- ism in the MPTP marmoset model [ J ]. J Neuroimmune Pharrnacol, 2013, 8(3) :715-726.
  • 9邓兴力,雷德强,刘如恩,等.帕金森病大鼠模型的建立[J].亡东医学,2012,33(3):313-315.
  • 10Berretta N, Freestone P S, Guatteo E, et al. Acute effects of 6-hydroxydopamine on dopaminergic neurons of the rat substantia nigra pars compacta in vitro [ J ]. Neurotoxicology, 2005, 26(5) :869-881.

引证文献6

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部